Kathryn Fagg appointed to NAB Board
The Chairman of National Australia Bank Limited, Dr Ken Henry, today announced the appointment of Ms Kathryn Fagg as a non-executive director of NAB, effective 16 December 2019.
Ms Fagg is a respected and experienced director and Chairman, with extensive leadership experience across a range of industries, including banking.
Dr Henry said: “While I will soon be resigning from the Board, on behalf of Philip Chronican (Chairman-elect) and our fellow directors, we are delighted Kathryn has accepted our invitation to join the Board and look forward to the diversity of thought, experience and skills she will bring.”
Ms Fagg said “I believe a strong banking system is essential for our nation’s economic wellbeing and I look forward to bringing my knowledge and experience from multiple sectors, including banking, to address the challenges and opportunities for NAB to earn the trust and respect of its shareholders, customers, employees and the broader community.”
Ms Fagg has been a board member of the Reserve Bank of Australia and was appointed an Officer of the Order of Australia (AO) in the 2019 Queen’s Birthday Honours for distinguished service to business and finance, to the central banking, logistics and manufacturing sectors and to women.
She is Chairman of Boral Limited and a non-executive director of Djerriwarrh Investments Limited and the CSIRO and will retire as a non-executive director of Incitec Pivot at the conclusion of their Annual General Meeting on 20 December 2019. Previously, she held executive roles with Linfox Logistics, Bluescope Steel and ANZ Bank. She started her career as an engineer with Esso Australia (now Exxon Mobil) and had consulting experience with McKinsey & Co.
Ms Fagg is Chairman of Breast Cancer Network Australia (BCNA) and is a former president of Chief Executive Women and a former Chairman of the Melbourne Recital Centre. She is also a board member of The Grattan Institute, The Myer Foundation and the Male Champions of Change.
Ms Fagg’s appointment is subject to regulatory approval.